Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Whole Blood for Gluteus Medius Tendinopathy
NCT02978833Phase 4Terminated
- Sponsor
- Hospital for Special Surgery
- Start
- Oct 2013
- Primary completion
- Jun 2017
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of platelet-rich plasma in gluteus medius tendinopathy (2 arms), sponsored by Hospital for Special Surgery. Primary endpoints: Improvement in Pain at 1 year, Improvement in Function at 1 year and 1 more. Started Oct 2013; status: terminated.
02
Drugs
platelet-rich plasma
03
Conditions
gluteus medius tendinopathy
Beyond the preview
Go deeper on NCT02978833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02978833.